Cite
HARVARD Citation
Kobayashi, S. et al. (2021). Anti‐FIRΔexon2 autoantibody as a novel indicator for better overall survival in gastric cancer. Cancer science. 112 (2), pp. 847-858. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kobayashi, S. et al. (2021). Anti‐FIRΔexon2 autoantibody as a novel indicator for better overall survival in gastric cancer. Cancer science. 112 (2), pp. 847-858. [Online].